Baker Bros. Advisors’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.38M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.54M | Hold |
|
|||||
|
2023
Q1 | $989K | Hold |
|
|||||
|
2022
Q4 | $1.53M | Hold |
|
|||||
|
2022
Q3 | $1.79M | Hold |
|
|||||
|
2022
Q2 | $1.72M | Hold |
|
|||||
|
2022
Q1 | $7.84M | Hold |
|
|||||
|
2021
Q4 | $16.2M | Hold |
|
|||||
|
2021
Q3 | $27.1M | Hold |
|
|||||
|
2021
Q2 | $23.7M | Hold |
|
|||||
|
2021
Q1 | $27M | Hold |
|
|||||
|
2020
Q4 | $26.8M | Sell |
|
|||||
|
2020
Q3 | $31.1M | Hold |
|
|||||
|
2020
Q2 | $40.5M | Buy |
|
|||||
|
2020
Q1 | $7.99M | Hold |
|
|||||
|
2019
Q4 | $13.1M | Hold |
|
|||||
|
2019
Q3 | $13.2M | Hold |
|
|||||
|
2019
Q2 | $11.7M | Hold |
|
|||||
|
2019
Q1 | $13.8M | Hold |
|
|||||
|
2018
Q4 | $12.8M | Buy |
|
|||||
|
2018
Q3 | $13.3M | Hold |
|
|||||
|
2018
Q2 | $14.7M | Buy |
|
|||||
|
2018
Q1 | $11.3M | Hold |
|
|||||
|
2017
Q4 | $6.16M | Hold |
|
|||||
|
2017
Q3 | $5.61M | Hold |
|
|||||
|
2017
Q2 | $4.38M | Buy |
|
|||||
|
2017
Q1 | $1.42M | Sell |
|
|||||
|
2016
Q4 | $1.76M | Hold |
|
|||||
|
2016
Q3 | $2.59M | Hold |
|
|||||
|
2016
Q2 | $1.97M | Buy |
|